Skip to Content

'
Khanh Vu, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1999 The University of Texas Medical School at Houston, Houston, TX, MD, Internal Medicine
1995 The University of Dallas, Irving, TX, BS, Biology

Postgraduate Training

1/1999-5/2002 Residency, Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX

Board Certifications

1/2002 Internal Medicine

Selected Publications

Peer-Reviewed Original Research Articles
1. Dougherty PM, Cata JP, Burton AW, Vu K, Weng HR. Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. J Pain Symptom Manage 33:166-79, 2/2007. PMID: 17280922.
2. Weiser MA, Cabanillas M, Vu K, Tamm EP, Wallace MJ, Escalante CP, Bresalier RS. Diagnostic evaluation of patients with a high suspicion of malignancy: comorbidities and clinical predictors of cancer. Am J Med Sci 330(1):11-8, 7/2005. PMID: 16020994.

Abstracts
1. Vu K, Yeung S-C, Thomas DA, Faderl S, Konopleva M, Busaidy N, Cabanillas M, Verma D, Escalante C, O'Brien S, Lavis V, Kantarjian H, Weiser MA. Effect of tight control of blood glucose during hyper-CVAD chemotherapy for acute lymphocytic leukemia. Blood 112(11):336 (#904), 2008.
2. Verma D, Faderl S, O'Brien S, Pierce S, Cortes J, Vu K, Freireich E, Keating MJ, Kantarjian HM, Ravandi F. Late relapses in acute myelogenous leukemia: Analysis of characteristics and outcome. Blood 112(11):350 (#951), 2008.
3. Vu K, Lavis VR, Strom S, Faderl SH, Konopleva M, Thomas DA, Gruschkus S, Andreeff M, Kantarjian H. Hyperglycemia and obesity in patients (pts) with acute lymphoblastic leukemia (ALL): Association with prevalence, response, and survival. J Clin Oncol 25(18S) (#7074), 2007.
4. Faderl S, Thomas DA, Ravandi F, Garcia-Manero G, Beran M, Rytting M, Koller CA, Verstovsek S, Borthakur G, Andreeff M, Kornblau S, O'Brien S, Vu K, Kwari M. Intensification of Hyper-CVAD with L-Asparaginase, Vincristine, and Dexamethasone ("augmented Hyper-CVAD") has activity in adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL). Blood 110(11):149b (#4324), 2007.
5. Vu K, Strom S, Konopleva M, Thomas D, Faderl S, Gruschkus S, Hubbbard J, Escalante C, Andreeff M, Kantarjian H, Lavis V. Prevalence of hyperglycemia and obesity in patients with newly diagnosed acute lymphoblastic leukemia (ALL). Proc American Diabetes Association, 2007.
6. Vu KD, Hubbard JC, Lin E, Faderl SH, Cortes JE, O'Brien SM, Kantarjian HM, Thomas DA. Venothromboembolism (VTE) in patients (pts) with acute lymphocytic leukemia (ALL), Burkitt's leukemia/lymphoma (BL) or lymphoblastic lymphoma (LL). Blood 110(11):152-153b (#4338), 2007.
7. Vu K, Thomas DA, Hubbard JC, Faderl S, Cortes J, Cabanillas ME, Garcia-Manero G, O'Brien SM, Kantarjian HM. Incidence of venothromboembolism (VTE) in patients (pts) with acute lymphocytic leukemia (ALL), Burkitt's leukemia/lymphoma (BL) or lymphoblastic leukemia (LL). Blood 108(11) (#4534b), 2006.
8. Faderl S, Thomas DA, Garcia-Manero G, Ravandi F, Beran M, Rytting M, Koller CA, Verstovsek S, Borthakur G, Andreeff M, Kornblau S, Vu K, Jarmon R, Kantarjian HMK. Augmented hyper-CVAD in acute lymphoblastic leukemia and vincristine in adult ALL salvage: The MDACC experience with intensified L-asparaginase and vincristine in adult ALL salvage. Blood 106(11):523a, 2005.
9. Cabanillas, ME, Mattiuzzi G, Thomas D, Vu K, Ossa G, Garcia-Manero G, Cortes J, Giles F, O’Brien S, Kantarjian H. Invasive fungal infections (IFI) in patients (pts) receiving hyper-CVAD. J Clin Oncol 23:6727, 2004.
10. Quintas-Cardama, A, Kantarjian H, O’Brien S, Vu K, Garcia-Manero G, Giles F, Rios MB, Talpaz M, Cortes J. Administration of G-CSF (Filgrastim, NeupogenTM) for imatinib mesylate (GleevecTM)-induced neutropenia in chronic phase chronic myeloid leukemia (CML) patients (pts) is safe and facilitates the achievement of cytogenetic responses. Blood 102:906a, 2003.

Last updated: 8/20/2009